ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

TGTX TG Therapeutics Inc

16,01
-0,41 (-2,50%)
04 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
TG Therapeutics Inc TGTX NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,41 -2,50% 16,01 01:00:02
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
16,75 15,96 17,00 16,19 16,42
mais cotações »

Notícias Recentes

Data Hora Fonte Título
01/05/202408:00GLOBETG Therapeutics Provides Business Update and Reports First..
30/04/202417:55GLOBETG Therapeutics to Host Conference Call on First Quarter..
18/04/202408:30GLOBETG Therapeutics Announces Additional Data Presentations for..
18/04/202408:00GLOBETG Therapeutics Awarded National Contract by the Department..
15/04/202408:30GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI®..
08/03/202409:30GLOBETG Therapeutics Announces Schedule of Data Presentations for..
01/03/202409:30GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI®..
28/02/202409:00GLOBETG Therapeutics Provides Business Update and Reports Fourth..
27/02/202409:30GLOBETG Therapeutics Announces Issuance of Additional Patents for..
26/02/202409:00GLOBETG Therapeutics Announces European Launch of BRIUMVI®..
23/02/202409:30GLOBETG Therapeutics to Host Conference Call on Fourth Quarter..
20/02/202409:30GLOBETG Therapeutics Announces Schedule of Data Presentations for..
10/01/202409:00GLOBETG Therapeutics Provides Preliminary Fourth Quarter and Full..
09/01/202411:20APSBiotech Massively Bid Up Before Opening Bell
09/01/202409:00GLOBETG Therapeutics Announces Global License Agreement with..
05/01/202409:30GLOBETG Therapeutics to Participate in the 42nd Annual J.P...
27/11/202309:30GLOBETG Therapeutics to Participate in the 6th Annual Evercore..
03/11/202308:30GLOBETG Therapeutics to Participate in the 5th Annual Guggenheim..
01/11/202308:30GLOBETG Therapeutics Provides Business Update and Reports Third..
30/10/202308:30GLOBETG Therapeutics to Host Conference Call on Third Quarter..
12/10/202312:00GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI..
11/10/202311:30GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI..
02/10/202308:30GLOBETG Therapeutics Announces Schedule of Data Presentations for..
22/09/202308:30GLOBETG Therapeutics to Participate in the 2023 Cantor Global..
07/09/202308:30GLOBETG Therapeutics to Participate in the H.C. Wainwright 25th..
01/08/202308:15GLOBETG Therapeutics Provides Business Update and Reports Second..
01/08/202308:00GLOBETG Therapeutics and Neuraxpharm Announce Ex-US..
31/07/202309:30GLOBETG Therapeutics to Host Conference Call on Second Quarter..
05/06/202308:30GLOBETG Therapeutics to Participate in the 2023 Jefferies..
02/06/202310:15GLOBETG Therapeutics Announces Presentation of Data from the..
01/06/202310:15GLOBETG Therapeutics Announces European Commission Approval for..
31/05/202308:30GLOBETG Therapeutics Announces Data from the ULTIMATE I & II..

Seu Histórico Recente

Delayed Upgrade Clock